Hyaluronic Acid Vaginal Suppository (HA 5 mg); Hyaluronic Acid Vaginal Suppository (HA 10 mg)— 510(k) K260007

Substantially Equivalent

Hudi Pharma Srl

FDA 510(k) clearance K260007 for Hyaluronic Acid Vaginal Suppository (HA 5 mg); Hyaluronic Acid Vaginal Suppository (HA 10 mg), Substantially Equivalent on 2026-04-01. Applicant: Hudi Pharma Srl.

Clearance details

Applicant: Hudi Pharma Srl
Product code: Code NUC
Advisory panel: Obstetrics/Gynecology
Date received: 2026-01-02
Decision date: 2026-04-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Milano, IT

Download summary PDF View on FDA.gov ↗

Adverse events under product code NUC

product code NUC

Other: 8
Total: 8

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.